Engineering microRNAs as multimodal cancer therapeutics

Rui Kang, Daolin Tang

Open source

DOI
10.1016/j.omtn.2026.103074
Published
2026-12
Container
Molecular Therapy Nucleic Acids
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtn.2026.103074,
  title = {Engineering microRNAs as multimodal cancer therapeutics},
  author = {Rui Kang and Daolin Tang},
  year = {2026},
  journal = {Molecular Therapy Nucleic Acids},
  doi = {10.1016/j.omtn.2026.103074},
  url = {https://doi.org/10.1016/j.omtn.2026.103074}
}

RIS

TY  - JOUR
TI  - Engineering microRNAs as multimodal cancer therapeutics
AU  - Rui Kang
AU  - Daolin Tang
PY  - 2026
JO  - Molecular Therapy Nucleic Acids
DO  - 10.1016/j.omtn.2026.103074
UR  - https://doi.org/10.1016/j.omtn.2026.103074
ER  - 

APA

Kang, R., & Tang, D. (2026). Engineering microRNAs as multimodal cancer therapeutics. Molecular Therapy Nucleic Acids. https://doi.org/10.1016/j.omtn.2026.103074

Source records